AIM: To estimate the bioequivalence of 2 roxithromycin capsules.
目的：评价2种罗红霉素胶囊的生物等效性。
AIM: To observe the relative bioavailability of domestic or import roxithromycin.
目的：进行国产与进口罗红霉素的生物利用度研究。
OBJECTIVE: To develop a method for assay of roxithromycin in electron medicinal membrane of roxithromycin.
目的：建立测定罗红霉素电子药膜中主药含量的方法。
The minimal bactericidal concentration(MBC) of roxithromycin was 4~16 times greater than the minimal inhibitory concentration(MIC).
国产罗红霉素对于所采用实验菌株的MBC要大于MIC的4～16倍。
A novel TLC method of roxithromycin was compared with the TLC method which was described in "the Japanese Standards of Antibiotics (1993)".
建立了罗红霉素新的TLC法，并与《日本抗生物质医药品基准解说》1993年版收载的方法进行了比较。
Methods The dissolution of roxithromycin capsules was analyzed with spectrophotometry. The dissolutive parameters of different products were compared.
方法采用分光光度法测定罗红霉素胶囊的体外溶出度，并对溶出参数进行相关性分析。
Methods: Chitosan was used to prepare the roxithromycin plastics. The quality controlling method was established and the clinical therapeutic effect was observed.
方法：选用壳聚糖为成膜材料，制备罗红霉素涂膜剂，并建立质量控制方法，进行临床疗效观察。
OBJECTIVE: to study the effect of roxithromycin on cellular immune function and to study its anti-inflammatory and immunoregulation effects beside its antibacterial effect.
目的：研究罗红霉素对免疫细胞功能的影响，探讨其除抗菌以外的抗炎和免疫调节作用。
The experimental process on synthesis of roxithromycin was studied by using erythromycin oxime and MEMC as raw material under the catalytic action of anhydrous sodium carbonate.
研究了以无水碳酸钠为催化剂，红霉素肟与甲氧基乙氧基氯甲醚(MEMC)为原料，一步合成罗红霉素的实验过程。
The invention provides a medicament containing roxithromycin, tinidazole and vitamin B2 and a preparation method thereof, belonging to the field of chemical medicine compositions.
本发明提供一种包含罗红霉素、替硝唑和维生素b2的药物及其制备方法。属于化学药物组合物领域。
Objective: To establish a microbial limit test method for Roxithromycin Tablets.
目的：验证一种罗红霉素片微生物限度检查的方法。
CONCLUSION: Roxithromycin may have anti-inflammation and immunoregulation effects.
结论：罗红霉素可能具有一定的抗炎和免疫调节作用。
But Roxithromycin sustained release pellets with smaller size show a better bioavailability.
但小粒径罗红霉素缓释微丸具有更高的生物利用度。
Roxithromycin, a new macrolide antibiotic, has an antibacterial spectrum similar to that of erythromycin.
罗红霉素为新型大环内酯类抗生素，其体外抗菌活性类似于母体化合物红霉素。
Objective to prepare Roxithromycin Hollow Suppository and to study its quality control in order to treat paediatric diseases.
目的制备治疗儿科疾病的罗红霉素中空栓剂并对其质量控制进行研究。
Methods:110 cases of mycoplasma urealytium genitourinary tract infection were randomly divided into 3 groups, group Azithromycin, group Roxithromycin, group Clarithromycin.
方法110例解脲支原体泌尿道感染患者随机分为：阿奇霉素组、 罗红霉素组、 克拉霉素组等3组。
CONCLUSION Roxithromycin has a protective effect on rat acute lung injury induced by LPS through regulating cytokines, improving gas exchange ability, and inhibiting lung permeability.
结论罗红霉素能改善大鼠急性肺损伤时气体交换能力，调节肺部细胞因子，对内毒素诱导的急性肺损伤有保护作用。
CONCLUSION Roxithromycin has a protective effect on rat acute lung injury induced by LPS through regulating cytokines, improving gas exchange ability, and inhibiting lung permeability.
结论罗红霉素能改善大鼠急性肺损伤时气体交换能力，调节肺部细胞因子，对内毒素诱导的急性肺损伤有保护作用。
应用推荐